Drug Discovery Market Research Reports & Industry Analysis

Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the Food & Drug Administration (FDA). The average drug can take 10+ years to progress from the discovery phase to the clinic, with only one compound out of 10,000 evolving into a viable product. Need for discovery is driven by the need for new products to market and sell. 

Sort by

Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021

21 Mar 2017  |  Published by:  DPI Research
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021. Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiativ...
$ 800.00 Read More

Infectious Disease Drugs: The Chinese Market

16 Mar 2017  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.INTRODUCTIONSTUDY GOALS AND OBJECTIVESThe Chinese infectious disease drug market is big, fast-growing a...
$ 5,550.00 Read More

2017-2022 Global Top Countries Drugs for Schistosomiasis Market Report

15 Mar 2017  |  Published by:  LP INFORMATION
This report studies Drugs for Schistosomiasis in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa,focuses on the top Manufacturers in each country, coveringShin PoongM...
$ 4,960.00 Read More

2017-2022 China Vegetarian Softgel Capsules Market Report (Status and Outlook)

14 Mar 2017  |  Published by:  LP INFORMATION
The Vegetarian Softgel Capsules market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In China market, the top players include many company. With key sales data like sales (volume), revenue, market sh...
$ 3,360.00 Read More

2017-2022 United States Drugs for Schistosomiasis Market Report (Status and Outlook)

14 Mar 2017  |  Published by:  LP INFORMATION
The Drugs for Schistosomiasis market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In United States market, the top players include many company. With key sales data like sales (volume), reve...
$ 3,360.00 Read More

2017-2022 India Vegetarian Softgel Capsules Market Report (Status and Outlook)

13 Mar 2017  |  Published by:  LP INFORMATION
The Vegetarian Softgel Capsules market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In India market, the top players include many company. With key sales data like sales (volume), revenue, market sh...
$ 3,360.00 Read More

2017-2022 Japan Drugs for Schistosomiasis Market Report (Status and Outlook)

13 Mar 2017  |  Published by:  LP INFORMATION
The Drugs for Schistosomiasis market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Japan market, the top players include many company. With key sales data like sales (volume), revenue, market shar...
$ 3,360.00 Read More

2017-2022 Malaysia Vegetarian Softgel Capsules Market Report (Status and Outlook)

10 Mar 2017  |  Published by:  LP INFORMATION
The Vegetarian Softgel Capsules market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Malaysia market, the top players include many company. With key sales data like sales (volume), revenue, mar...
$ 3,360.00 Read More

2017-2022 Philippines Drugs for Schistosomiasis Market Report (Status and Outlook)

10 Mar 2017  |  Published by:  LP INFORMATION
The Drugs for Schistosomiasis market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Philippines market, the top players include many company. With key sales data like sales (volume), revenue,...
$ 3,360.00 Read More

2017-2022 China Drugs for Schistosomiasis Market Report (Status and Outlook)

09 Mar 2017  |  Published by:  LP INFORMATION
The Drugs for Schistosomiasis market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In China market, the top players include many company. With key sales data like sales (volume), revenue, market shar...
$ 3,360.00 Read More

2017 Top 5 Drugs for Schistosomiasis Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa

07 Mar 2017  |  Published by:  LP INFORMATION
This report studies Drugs for Schistosomiasis in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Drugs for Schistosomiasis Players in each region, with sales, price, revenue and market share for top 5 manufacturer, coverin...
$ 4,960.00 Read More

2017-2022 India Drugs for Schistosomiasis Market Report (Status and Outlook)

07 Mar 2017  |  Published by:  LP INFORMATION
The Drugs for Schistosomiasis market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In India market, the top players include many company. With key sales data like sales (volume), revenue, market shar...
$ 3,360.00 Read More

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

07 Mar 2017  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for over the counter (OTC) drugs and dietary supplements reached $164.7 billion in 2016 and should reach $220.8 billion in 2021, with a compound annual growth rate (CAGR) of 6.0%.INTRODUCTIONSTUDY GOALS AND OBJECTIVESThe study goal of this report is to understand the OTC drugs and ...
$ 6,650.00 Read More

Antifungal Drugs: Technologies and Global Markets

07 Mar 2017  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for antifungal drugs was valued at $13.1 billion in 2016. The market should reach $16.1 billion by 2021, growing at a compound annual growth rate (CAGR) of 4.2% from 2016 to 2021.INTRODUCTION TO THE REPORTThe goal of BCC Research in conducting this study was to determine the curren...
$ 6,650.00 Read More

2017-2022 Japan Vegetarian Softgel Capsules Market Report (Status and Outlook)

06 Mar 2017  |  Published by:  LP INFORMATION
The Vegetarian Softgel Capsules market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Japan market, the top players include many company. With key sales data like sales (volume), revenue, market sh...
$ 3,360.00 Read More
  • 1070 Results